STOCK TITAN

Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Alector (Nasdaq: ALEC), a clinical-stage biotechnology company specializing in immuno-neurology, will present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024. The event will be held virtually, and Alector's management will participate in a corporate presentation. Interested parties can access the webcast on the 'Events & Presentations' page of the Alector website starting at 7:00 a.m. ET. A replay of the presentation will be available on the website for 90 days post-event.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a corporate presentation at the H.C. Wainwright 5th Annual Neuro Perspectives Conference, being held virtually on Thursday, June 27, 2024.

A webcast of the presentation will be available on the “Events & Presentations” page at 7:00 a.m. ET within the Investors section of the Alector website at http://investors.alector.com. A replay will be available on the Alector website for 90 days following the event.

About Alector
Alector is a clinical-stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. Alector has discovered and is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brain’s immune system and enable rejuvenated immune cells to counteract emerging brain pathologies. Alector’s immuno-neurology product candidates are supported by biomarkers and seek to treat indications, including Alzheimer’s disease and genetically defined frontotemporal dementia patient populations. Alector is headquartered in South San Francisco, California. For additional information, please visit www.alector.com.

Alector Contacts:

Alector
Katie Hogan
202-549-0557
katie.hogan@alector.com

1AB (media)
Dan Budwick
973-271-6085
dan@1abmedia.com

Argot Partners (investors)
Laura Perry
212.600.1902
alector@argotpartners.com


FAQ

When is Alector presenting at the H.C. Wainwright Neuro Perspectives Conference?

Alector is presenting on June 27, 2024.

How can I watch Alector's presentation at the Neuro Perspectives Conference?

You can watch the presentation on the 'Events & Presentations' page of the Alector website starting at 7:00 a.m. ET on June 27, 2024.

Will there be a replay available for Alector's presentation at the Neuro Perspectives Conference?

Yes, a replay will be available on the Alector website for 90 days following the event.

What time is Alector's presentation available for viewing?

The presentation will be available at 7:00 a.m. ET on June 27, 2024.

Where can I find the webcast of Alector's presentation at the Neuro Perspectives Conference?

The webcast will be available on the 'Events & Presentations' page within the Investors section of the Alector website.

Alector, Inc.

NASDAQ:ALEC

ALEC Rankings

ALEC Latest News

ALEC Stock Data

466.17M
97.32M
8.78%
86.1%
4.21%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
SOUTH SAN FRANCISCO